| Trial ID: | L7070 |
| Source ID: | NCT01978405
|
| Associated Drug: |
Alpha Lipoic Acid
|
| Title: |
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Kidney Injury|The Changes of Plasma Creatinine|The Changes of Plasma Free Radicals|The Changes of Endothelium-dependent Arterial Dilation
|
| Interventions: |
DRUG: Alpha lipoic acid
|
| Outcome Measures: |
Primary: Contrast induced acte kidney injury, 6 months|The changes of endothelium-dependent arterial dilation before and after contrast administrated, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Xiang Guang-da
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
|
| Start Date: |
2013-11
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-08
|
| Locations: |
Wuhan General Hospital, Wuhan, Hubei, 430070, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01978405
|
